Skip to main content
MedicineBase by Home Med Cabinet

Medicine · Spain

BENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Injection

Home Med Cabinet

Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record

Synchronized

At a glance

Active ingredient
Pharmaceutical form Home Med Cabinet grouping
Injection
Availability in Spain
2 of 4 packs marketed

Packs

  • BENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 25 mg

    5 pcs

    National code727689

    Marketed

    Strength of this pack 25 mg

  • BENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 5 viales de 100 mg

    5 pcs

    National code727690

    Marketed

    Strength of this pack 100 mg

  • BENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 25 mg

    1 pcs

    National code729168

    Not marketed

    Strength of this pack 25 mg

  • BENDAMUSTINA HIKMA 2,5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 100 mg

    1 pcs

    National code729522

    Not marketed

    Strength of this pack 100 mg

“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.

Official documents

Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.

Registration

Registration number
84770Official data
Marketing authorisation holder
HIKMA FARMACEUTICA (PORTUGAL) S.A.Official data
Authorised
Dec 30, 2019Official data
Authority form code
1403Official data

Classification

ATC classification is not published here yet

Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.

Source

Official data

Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)

CIMA — Centro de Información de Medicamentos · Spain

Updated
Not provided for this source record
Synchronized
Oct 2, 2026

Back to search